Literature DB >> 27896572

Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis.

Yongwei Wang1,2, Yali Du3, Gang Liu2,4, Shanshan Guo2, Bo Hou5, Xianyong Jiang3, Bing Han6, Yanzhong Chang7, Guangjun Nie8.   

Abstract

Hereditary hemochromatosis (HH) is a group of inherited iron-overload disorders associated with pathogenic defects in the genes encoding hemochromatosis (HFE), hemojuvelin (HJV/HFE2), hepcidin (HAMP), transferrin receptor 2 (TfR2), and ferroportin (FPN1/SLC40A1) proteins, and the clinical features are well described. However, there have been only a few detailed reports of HH in Chinese populations. Thus, there is insufficient patient information for population-based analyses in Chinese populations or comparative studies among different ethical groups. In the current work, we describe eight Chinese cases of hereditary hemochromatosis. Gene sequencing results revealed eight mutations (five novel mutations) in HFE, HFE2, TfR2, and SLC40A1 genes in these Chinese HH patients. In addition, we used Polymorphism Phenotyping v2 (Polyphen), Sorting Intolerant From Tolerant (SIFT), and a sequence alignment program to predict the molecular consequences of missense mutations.

Entities:  

Keywords:  Chinese patients; Hereditary hemochromatosis; Novel mutations

Mesh:

Substances:

Year:  2016        PMID: 27896572     DOI: 10.1007/s12185-016-2150-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

1.  Mutation analysis of the transferrin receptor-2 gene in patients with iron overload.

Authors:  P L Lee; C Halloran; C West; E Beutler
Journal:  Blood Cells Mol Dis       Date:  2001 Jan-Feb       Impact factor: 3.039

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction?

Authors:  Silvia Majore; Bianca Maria Ricerca; Francesca Clementina Radio; Francesco Binni; Ilaria Cosentino; Giulia Gallusi; Carmelilia De Bernardo; Aldo Morrone; Paola Grammatico
Journal:  Blood Cells Mol Dis       Date:  2012-09-11       Impact factor: 3.039

4.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation.

Authors:  A T McKie; P Marciani; A Rolfs; K Brennan; K Wehr; D Barrow; S Miret; A Bomford; T J Peters; F Farzaneh; M A Hediger; M W Hentze; R J Simpson
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

5.  Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene.

Authors:  Weidong Liu; Souji Shimomura; Hiroyasu Imanishi; Yuna Iwamoto; Naoto Ikeda; Masaki Saito; Masao Ohno; Naoki Hara; Tetsuo Yamamoto; Hideji Nakamura; Toshikazu Hada
Journal:  Intern Med       Date:  2005-04       Impact factor: 1.271

6.  Identification of a novel mutation (C321X) in HJV.

Authors:  Franklin W Huang; Isabel Rubio-Aliaga; James P Kushner; Nancy C Andrews; Mark D Fleming
Journal:  Blood       Date:  2004-05-11       Impact factor: 22.113

7.  Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.

Authors:  George Papanikolaou; Mark E Samuels; Erwin H Ludwig; Marcia L E MacDonald; Patrick L Franchini; Marie-Pierre Dubé; Lisa Andres; Julie MacFarlane; Nikos Sakellaropoulos; Marianna Politou; Elizabeta Nemeth; Jay Thompson; Jenni K Risler; Catherine Zaborowska; Ryan Babakaiff; Christopher C Radomski; Terry D Pape; Owen Davidas; John Christakis; Pierre Brissot; Gillian Lockitch; Tomas Ganz; Michael R Hayden; Y Paul Goldberg
Journal:  Nat Genet       Date:  2003-11-30       Impact factor: 38.330

Review 8.  Ironing out Ferroportin.

Authors:  Hal Drakesmith; Elizabeta Nemeth; Tomas Ganz
Journal:  Cell Metab       Date:  2015-10-01       Impact factor: 27.287

Review 9.  Hereditary hemochromatosis--a new look at an old disease.

Authors:  Antonello Pietrangelo
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

  9 in total
  8 in total

Review 1.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

2.  Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis.

Authors:  Wei Zhang; Yanmeng Li; Anjian Xu; Qin Ouyang; Liyan Wu; Donghu Zhou; Lina Wu; Bei Zhang; Xinyan Zhao; Yu Wang; Xiaoming Wang; Weijia Duan; Qianyi Wang; Hong You; Jian Huang; Xiaojuan Ou; Jidong Jia
Journal:  Orphanet J Rare Dis       Date:  2022-06-06       Impact factor: 4.303

Review 3.  Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.

Authors:  Xiaomu Kong; Lingding Xie; Haiqing Zhu; Lulu Song; Xiaoyan Xing; Wenying Yang; Xiaoping Chen
Journal:  Orphanet J Rare Dis       Date:  2019-07-08       Impact factor: 4.123

4.  Clinicopathological diagnosis and treatment of juvenile hemochromatosis.

Authors:  Chun-Xing Li; Liang Zhang; Peng Wang; Lei Sun
Journal:  Chin Med J (Engl)       Date:  2019-12-20       Impact factor: 2.628

5.  Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China.

Authors:  Liyan Wu; Wei Zhang; Yanmeng Li; Donghu Zhou; Bei Zhang; Anjian Xu; Zhen Wu; Lina Wu; Shuxiang Li; Xiaoming Wang; Xinyan Zhao; Qianyi Wang; Min Li; Yu Wang; Hong You; Jian Huang; Xiaojuan Ou; Jidong Jia
Journal:  Orphanet J Rare Dis       Date:  2021-09-28       Impact factor: 4.123

6.  Primary haemochromatosis resulting in dilated cardiomyopathy arising out of mutation in HJV gene in Indian patients: a rare scenario.

Authors:  Abhishek Goyal; Bishav Mohan; Kavita Saggar; Gurpreet Singh Wander
Journal:  BMJ Case Rep       Date:  2020-09-16

Review 7.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09

8.  MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.

Authors:  André Viveiros; Benedikt Schaefer; Marlene Panzer; Benjamin Henninger; Michaela Plaikner; Christian Kremser; André Franke; Sören Franzenburg; Marc P Hoeppner; Reinhard Stauder; Andreas Janecke; Herbert Tilg; Heinz Zoller
Journal:  Hepatology       Date:  2021-07-13       Impact factor: 17.425

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.